Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 340701, 7 pages
http://dx.doi.org/10.1155/2014/340701
Research Article

Curcumin Loaded Microsponges for Colon Targeting in Inflammatory Bowel Disease: Fabrication, Optimization, and In Vitro and Pharmacodynamic Evaluation

School of Pharmaceutical Sciences, Shoolini University, Bajhol, Solan, Himachal Pradesh 173229, India

Received 5 February 2014; Revised 10 May 2014; Accepted 28 May 2014; Published 1 July 2014

Academic Editor: Florence Siepmann

Copyright © 2014 Rashmi Sareen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Talaei, F. Atyabi, M. Azjdarzadeh, R. Dinarvand, and A. Saadatzadeh, “Overcoming therapeutic obstacles in inflammatory bowel diseases: a comprehensive review on novel drug delivery strategies,” European Journal of Pharmaceutical Sciences, vol. 49, no. 4, pp. 712–722, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. V. Jaleh, E. Jaber, T. Naser, M. Mohsen, R. Nakisa, and D. Farid, “Development and evaluation of a novel pellet-based tablet system for potential colon delivery of budesonide,” Journal of Drug Delivery, vol. 2012, Article ID 905191, 7 pages, 2012. View at Publisher · View at Google Scholar
  3. R. Sareen, N. Jain, and K. L. Dhar, “Development of colon specific microspheres of flurbiprofen for inflammatory bowel disease,” Current Drug Delivery, vol. 10, no. 5, pp. 564–671, 2013. View at Publisher · View at Google Scholar
  4. R. Sareen, N. Jain, and K. L. Dhar, “An insight to colon targeted drug delivery system,” Drug Delivery Letters, vol. 3, no. 2, pp. 127–135, 2013. View at Publisher · View at Google Scholar
  5. R. Srivastava and K. Pathak, “Microsponges: a futuristic approach for oral drug delivery,” Expert Opinion on Drug Delivery, vol. 9, no. 7, pp. 863–878, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Amrutiya, A. Bajaj, and M. Madan, “Development of microsponges for topical delivery of mupirocin,” AAPS PharmSciTech, vol. 10, no. 2, pp. 402–409, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Sareen, N. Jain, and V. Pandit, “Curcumin: a boon to colonic diseases,” Current Drug Targets, vol. 14, no. 10, pp. 1210–1218, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. M.-X. Ye, Y. Li, H. Yin, and J. Zhang, “Curcumin: updated molecular mechanisms and intervention targets in human lung cancer,” International Journal of Molecular Sciences, vol. 13, no. 3, pp. 3959–3978, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Karewicz, D. Bielska, B. Gzyl-Malcher, M. Kepczynski, R. Lach, and M. Nowakowska, “Interaction of curcumin with lipid monolayers and liposomal bilayers,” Colloids and Surfaces B: Biointerfaces, vol. 88, no. 1, pp. 231–239, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. H. A. Aziz, K. K. Peh, and Y. T. F. Tan, “Solubility of core materials in aqueous polymeric solution effect on microencapsulation of curcumin,” Drug Development and Industrial Pharmacy, vol. 33, no. 11, pp. 1263–1272, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Z. I. Khan, H. P. Štedul, and N. Kurjaković, “A pH-dependent colon-targeted oral drug delivery system using methacrylic acid copolymers. II. Manipulation of drug release using Eudragit L100 and Eudragit S100 combinations,” Drug Development and Industrial Pharmacy, vol. 26, no. 5, pp. 549–554, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Srivastava, D. Kumar, and K. Pathak, “Colonic luminal surface retention of meloxicam microsponges delivered by erosion based colon-targeted matrix tablet,” International Journal of Pharmaceutics, vol. 427, no. 2, pp. 153–162, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Perge, M. Robitzer, C. Guillemot, J. Devoisselle, F. Quignard, and P. Legrand, “New solid lipid microparticles for controlled ibuprofen release: formulation and characterization study,” International Journal of Pharmaceutics, vol. 422, no. 1-2, pp. 59–67, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Sareen, S. Kumar, and G. D. Gupta, “Meloxicam carbopol-based gels: characterization and evaluation,” Current Drug Delivery, vol. 8, no. 4, pp. 407–415, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. K. S. Parvathy, P. S. Negi, and P. Srinivas, “Antioxidant, antimutagenic and antibacterial activities of curcumin-β-diglucoside,” Food Chemistry, vol. 115, no. 1, pp. 265–271, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Jose, M. T. Prema, A. J. Chacko, A. C. Thomas, and E. B. Souto, “Colon specific chitosan microspheres for chronotherapy of chronic stable angina,” Colloids and Surfaces B: Biointerfaces, vol. 83, no. 2, pp. 277–283, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Nath and L. K. Nath, “development and optimization of oral colon targeted delivery system of azathioprine using biodegradable polymers,” Pharmaceutical Development and Technology, vol. 18, pp. 1131–1139, 2013. View at Google Scholar
  18. W. S. Omwancha, R. Mallipeddi, B. L. Valle, and S. H. Neau, “Chitosan as a pore former in coated beads for colon specific drug delivery of 5-ASA,” International Journal of Pharmaceutics, vol. 441, no. 1-2, pp. 343–351, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Tahan, E. Aytac, H. Aytekin et al., “Vitamin e has a dual effect of anti-inflammatory and antioxidant activities in acetic acid-induced ulcerative colitis in rats,” Canadian Journal of Surgery, vol. 54, no. 5, pp. 333–338, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. A. D. Kandhare, K. S. Raygude, P. Ghosh et al., “Effect of hydroalcoholic extract of Hibiscus rosa sinensis Linn. leaves in experimental colitis in rats,” Asian Pacific Journal of Tropical Biomedicine, vol. 2, no. 5, pp. 337–344, 2012. View at Google Scholar · View at Scopus
  21. S. U. Gandhy, K. Kim, L. Larsen, R. J. Rosengren, and S. Safe, “Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs,” BMC Cancer, vol. 12, article 564, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Cetinkaya, E. Bulbuloglu, E. B. Kurutas, H. Ciralik, B. Kantarceken, and M. A. Buyukbese, “Beneficial effects of N-acetylcysteine on acetic acid-induced colitis in rats,” The Tohoku Journal of Experimental Medicine, vol. 206, no. 2, pp. 131–139, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Barollo, V. Medici, R. D'Incà et al., “Antioxidative potential of a combined therapy of anti TNFα and Zn acetate in experimental colitis,” World Journal of Gastroenterology, vol. 17, no. 36, pp. 4099–4103, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. D. G. Yu, Y. Xu, Z. Li, L. P. Du, B. G. Zhao, and X. Wang, “Coaxial electrospinning with mixed solvents: from flat to round eudragit L100 nanofibers for better colon-targeted sustained drug release profiles,” Journal of Nanomaterials, vol. 2014, Article ID 967295, 8 pages, 2014. View at Publisher · View at Google Scholar